North Sea Therapeutics Appoints Melissa Bradford Klug As Chief Financial Officer and Chief Business Officer, and Sophie Jeannin As Chief Medical Officer
North Sea Therapeutics Appoints Melissa Bradford Klug As Chief Financial Officer and Chief Business Officer, and Sophie Jeannin As Chief Medical Officer
02/20/25, 12:11 PM
Location
amsterdamIndustry
biotechnology
health care
Position
chief medical officer
chief business officer
chief financial officer
NorthSea Therapeutics announced the appointments of Melissa Bradford-Klug as the Chief Financial Officer and Chief Business Officer, and Sophie Jeannin as the Chief Medical Officer. These appointments bring a combination of strategic leadership capabilities and deep expertise in biotechnology innovation to NorthSea’s team at a pivotal stage.
Company Info
Location
amsterdam, north holland, netherlands
Additional Info
NorthSea Therapeutics is a clinical-stage biotech company located in the US and Europe. The company focuses on developing novel therapeutic strategies for orphan metabolic, inflammatory, and fibrotic diseases. As a forward-thinking organization, NorthSea Therapeutics is dedicated to advancing the field of healthcare through innovative solutions.